Free Trial
OTCMKTS:BPSR

Organicell Regenerative Medicine (BPSR) Stock Price, News & Analysis

Organicell Regenerative Medicine logo
$0.06
+0.01 (+22.45%)
(As of 11/5/2021)

About Organicell Regenerative Medicine Stock (OTCMKTS:BPSR)

Key Stats

Today's Range
$0.05
$0.06
50-Day Range
$1.70
$2.68
52-Week Range
$0.04
$0.63
Volume
3.10 million shs
Average Volume
3.31 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotech Products Services & Research, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Miami, FL.

Receive BPSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter.

BPSR Stock News Headlines

Zeo ScientifiX, Inc. (ZEOX)
Blackrock’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Organicell Regenerative Medicine Inc (OCELD)
OCELD Organicell Regenerative Medicine, Inc.
Organicell Announces 1-for-200 Reverse Stock Split
See More Headlines

BPSR Stock Analysis - Frequently Asked Questions

Organicell Regenerative Medicine's stock was trading at $1.02 at the start of the year. Since then, BPSR shares have decreased by 94.1% and is now trading at $0.06.
View the best growth stocks for 2024 here
.

Shares of BPSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Organicell Regenerative Medicine investors own include Aurora Cannabis (ACB), NVIDIA (NVDA), 22nd Century Group (XXII), BioNTech (BNTX), Evofem Biosciences (EVFM), Inseego (INSG) and American Lithium (LIACF).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:BPSR
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:BPSR) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners